James Bradner

James Bradner

Novartis Institutes for BioMedical Research
在 novartis.com 的电子邮件经过验证
被引用次数：60405
Chemical Biology Chromatin Biology Cancer Biology Targeted Protein Degradation Drug Discovery
Rituraj Pal

Rituraj Pal

Baylor College of Medicine
在 bcm.edu 的电子邮件经过验证
被引用次数：10676
Targeted protein degradation Autophagy Oncology Neurodegenerative disorders Lysosomal storage disorders
Alessio Ciulli

Alessio Ciulli

Professor, University of Dundee
在 dundee.ac.uk 的电子邮件经过验证
被引用次数：8538
Chemical Biology Medicinal Chemistry Targeted Protein Degradation PROTACs Drug Discovery
Hannes Hahne

Hannes Hahne

OmicScouts GmbH
在 omicscouts.com 的电子邮件经过验证
被引用次数：6793
Proteomics Systems Biology Drug Discovery Targeted Protein Degradation
Zoran Rankovic

Zoran Rankovic

St. Jude Children's Research Hospital
在 stjude.org 的电子邮件经过验证
被引用次数：5755
medicinal chemistry drug discovery targeted protein degradation
Gang Lu

Gang Lu

President & CEO, GluBio Therapeutics
被引用次数：5328
Targeted Protein Degradation
Jan M Suski

Jan M Suski

Harvard Medical School
在 dfci.harvard.edu 的电子邮件经过验证
被引用次数：4504
Cell cycle Cancer Targeted Protein Degradation Genetic engineering Mitochondria
Kristin M. Riching

Kristin M. Riching

Promega Corporation
在 promega.com 的电子邮件经过验证
被引用次数：4130
Targeted protein degradation small molecule drug discovery
Patrick Ryan Potts

Patrick Ryan Potts

Amgen
在 amgen.com 的电子邮件经过验证
被引用次数：3986
ubiquitin targeted protein degradation oncology
Max Jan

Max Jan

Massachusetts General Hospital
在 partners.org 的电子邮件经过验证
被引用次数：3763
targeted protein degradation synthetic biology cell engineering
1 - 10